Advances in Universal CAR-T Cell Therapy
Chimeric antigen receptor T (CAR-T) cell therapy achieved extraordinary achievements results in antitumor treatments, especially against hematological malignancies, where it leads to remarkable, long-term antineoplastic effects with higher target specificity. Nevertheless, some limitations persist i...
Main Authors: | Haolong Lin, Jiali Cheng, Wei Mu, Jianfeng Zhou, Li Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.744823/full |
Similar Items
-
Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
by: Michael A. Morgan, et al.
Published: (2020-08-01) -
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
by: Jiangtao Ren, et al.
Published: (2017-04-01) -
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
by: Dok Hyun Yoon, et al.
Published: (2018-01-01) -
Could the menagerie of the gut microbiome really cure cancer? Hope or hype
by: Muhammad Bilal Abid
Published: (2019-04-01) -
The Pharmacology of T Cell Therapies
by: Michael C. Milone, et al.
Published: (2018-03-01)